Vicadrostat is under clinical development by Boehringer Ingelheim International and currently in Phase III for Chronic Kidney Disease (Chronic Renal Failure).
Brain-computer interfaces are rapidly evolving. Here are six scientists shaping the field
Nearly 20 years after neuroscientist John Donoghue placed electrodes on Matthew Nagle’s motor cortex, allowing the man with no limb movement to control objects using